OCUL — Ocular Therapeutix Balance Sheet
0.000.00%
- $1.22bn
- $799.45m
- $58.44m
- 54
- 15
- 88
- 51
Annual balance sheet for Ocular Therapeutix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 54.4 | 228 | 164 | 102 | 196 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.55 | 12.3 | 21.1 | 21.3 | 26.2 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 60.2 | 246 | 191 | 130 | 232 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 16.8 | 13.9 | 11.8 | 17.9 | 18.2 |
Other Long Term Assets | |||||
Total Assets | 78.7 | 262 | 205 | 149 | 252 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 12 | 26.7 | 26.3 | 31.4 | 34.9 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 82.4 | 186 | 117 | 114 | 161 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -3.63 | 76.1 | 88 | 35.4 | 91.1 |
Total Liabilities & Shareholders' Equity | 78.7 | 262 | 205 | 149 | 252 |
Total Common Shares Outstanding |